Please use this identifier to cite or link to this item:
https://dspace.ffh.bg.ac.rs/handle/123456789/1947
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Petković, J. | en_US |
dc.contributor.author | Minić, Dragica | en_US |
dc.contributor.author | Korićanac, Z. | en_US |
dc.contributor.author | Antić Jovanović, Ankica | en_US |
dc.date.accessioned | 2022-12-21T16:59:46Z | - |
dc.date.available | 2022-12-21T16:59:46Z | - |
dc.date.issued | 1998-01-01 | - |
dc.identifier.issn | 0031-7144 | en |
dc.identifier.uri | https://dspace.ffh.bg.ac.rs/handle/123456789/1947 | - |
dc.description.abstract | A simple and rapid method for the determination of famotidine is described. Famotidine is titrated with a solution of palladium(II)-chloride in Britton-Robinson buffer (pH = 3.60) using a silver indicator electrode. A stable yellow complex is formed. A significant step of the potential appears when the stoichiometric ratio of palladium(II) to famotidine is 1:1. The method is suitable for the determination of micro quantities (2.5-0.8 mg) of famotidine alone or in pharmaceutical dosage farms with a relative standard deviation of 0.7-2.3%. | en |
dc.relation.ispartof | Pharmazie | en |
dc.title | Potentiometric determination of famotidine in pharmaceutical dosage forms | en_US |
dc.type | Article | en_US |
dc.identifier.scopus | 2-s2.0-0031822702 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/0031822702 | - |
dc.relation.firstpage | 163 | en |
dc.relation.lastpage | 164 | en |
dc.relation.issue | 3 | en |
dc.relation.volume | 53 | en |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
crisitem.author.orcid | 0000-0001-5055-2039 | - |
Appears in Collections: | Journal Article |
SCOPUSTM
Citations
17
checked on Jan 6, 2025
Page view(s)
12
checked on Jan 6, 2025
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.